Psoriasis as an adverse reaction to biologic agents beyond anti-TNF-α therapy
European Journal of Dermatology · 2021-06 · 31 (3) · 307-317
DOI: 10.1684/ejd.2021.4056 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift European Journal of Dermatology, 2021-06. Verfasst von Anastasios Karamanakos und 5 weiteren Autor:innen. Beteiligte Einrichtung: Joint Rheumatology Program, 1st Department of Propaedeutic Internal Medicine-Rheumatology Unit, National and Kapodistrian University of Athens, Schoo…. Die Arbeit wurde bisher 23-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Joint Rheumatology Program, 1st Department of Propaedeutic Internal Medicine-Rheumatology Unit, National and Kapodistrian University of Athens, School of Medicine, Laikon General Hospital, Ag. Thoma 17, 11527, Athens, G…
- 1st University Clinic, Department of Dermatology-Venereology, National and Kapodistrian University of Athens, School of Medicine, A. Sygros Hospital, I. Dragoumi 5, 16121, Athens, Greece.
Zitieren
APA
Karamanakos, A., Vergou, T., Panopoulos, S., Tektonidou, M. G., Stratigos, A. J., & Sfikakis, P. P. (2021). Psoriasis as an adverse reaction to biologic agents beyond anti-TNF-α therapy. European Journal of Dermatology, 31(3), 307-317. https://doi.org/10.1684/ejd.2021.4056
Vancouver
Karamanakos A, Vergou T, Panopoulos S, Tektonidou MG, Stratigos AJ, Sfikakis PP. Psoriasis as an adverse reaction to biologic agents beyond anti-TNF-α therapy. European Journal of Dermatology. 2021;31(3):307-317. doi:10.1684/ejd.2021.4056
BibTeX
@article{Karamanakos2021,
author = {Karamanakos, Anastasios and Vergou, Theognosia and Panopoulos, Stylianos and Tektonidou, Maria G and Stratigos, Alexander J and Sfikakis, Petros P},
title = {Psoriasis as an adverse reaction to biologic agents beyond anti-TNF-α therapy},
journal = {European Journal of Dermatology},
year = {2021},
volume = {31},
number = {3},
pages = {307--317},
doi = {10.1684/ejd.2021.4056}
}
EUVIMED